AnteoTech Limited (ASX:ADO)
Australia flag Australia · Delayed Price · Currency is AUD
0.0070
-0.0010 (-12.50%)
Apr 24, 2025, 4:10 PM AEST

AnteoTech Company Description

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, North America, and Latin America.

Its products include AnteoBind, s an activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit , a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation.

The company also offers AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries.

In addition, it provides contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019.

AnteoTech Limited is headquartered in Eight Mile Plains, Australia.

AnteoTech Limited
AnteoTech logo
Country Australia
Industry Biotechnology
Sector Healthcare
Employees 99
CEO Merrill Gray

Contact Details

Address:
Brisbane Technology Park
Eight Mile Plains, 4113
Australia
Phone 61 7 3219 0085
Website anteotech.com

Stock Details

Ticker Symbol ADO
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU000000ADO8
SIC Code 2890

Key Executives

Name Position
Merrill Christina Gray AFAIM, B.Min.Tech, B.Sc, M.B.A., MAusIMM Interim Chief Executive Officer, MD and Director
Andrew Cook Chief Financial Officer and Company Secretary
Katrina Byrne Chief Operating Officer
Dr. N. Joe Maeji B.Sc., Ph.D. Founder and Chief Scientific Officer
Manuel Wieser Chief Technology Officer
Tsui Min Lian Chief Marketing Officer
Selahattin Guldu Executive Vice President of Commercial Banking
Ian Steinhardt Head of Market Operations for Life Sciences
Friederike Graser Director of Strategic Growth Initiatives